Newcomers Bradley, Curran win CVS Health Charity Classic golf tournament
BARRINGTON, R.I. — Keegan Bradley and Jon Curran claimed the golf title at the 17th annual CVS Health Charity Classic on Tuesday, posting 21-under-par 121. Lexi Thompson and Harris English took second place at 19-under-par, and Billy Horschel and Jimmy Walker finished at third place, with a 18-under-par 124.
Since 1999, the tournament has raised more than $18 million for non-profit organizations across Southern New England and attracted PGA, LPGA and Champions Tours players.
This year’s tournament sponsored the inaugural Charity Miles campaign, sponsored by Aon Hewitt. The program asked fans to download its app and raise money for a designated charity while walking, running and biking. So far, fans have raised $25,000.
Dr. Reddy’s introduces new logo, brand identity
G.V. Prasad, Co-chairman& CEO of Dr. Reddy's, at an event at the company's North American headquarters in Princeton, N.J. on Wednesday.
HYDERABAD, India — Dr. Reddy’s on Wednesday announced a rebranding, with a new logo meant to give the company a new, more visual identity.
The new purple logo is meant to express the dynamism, creativity and empathy — three values at the heart of its commitment to patients, Dr. Reddy's noted in a statement.
The rebranding, which will unify the brand and display the company’s willingness to meet new challenges, will extend to all Dr. Reddy’s product packaging once the legal processes and documentation necessary is complete. For the company, it is aimed at putting a fresh look on its five core principles: bringing expensive medicines within reach of patients who need them; addressing unmet patient needs; helping patients manage their disease better, working with partners to help them succeed and enabling product availability at pharmacy.
“Over 31 years, Dr. Reddy’s has grown from a manufacturer of APIs into a multinational pharmaceutical brand of repute, with operations in over 25 countries,” Dr. Reddy’s Chairman Satish Reddy said. “Throughout this journey, we have remained true to our core values, even as we continually transform to keep pace with the changing needs of our patients and partners. Our belief ‘Good Health Can’t Wait’ lends new meaning to our core purpose of accelerating access to affordable and innovative medicines.”
Teva launches generic Aggrenox in United States
JERUSALEM — Teva Pharmaceuticals announced the U.S.-wide availability of generic Aggrenox (aspirin and extended-release dipyridamole) capsules, which contain that can reduce the risk of stroke, on Wednesday.
“Teva recognizes the devastating impact of a stroke and is pleased to launch generic aspirin and extended-release dipyridamole capsules as a treatment option for at-risk stroke patients,” Brendan O’Grady, Teva’s president and CEO of North America Generic Medicines, said.
The National Institutes of Health estimates 185,000 Americans are at risk of another stroke within five years of a previous stroke. Every year, more than 795,000 Americans have a stroke, and 25% have had a previous stroke.